Top-News
Professionelle Dienstleistungen USA

NeuroBo Pharmaceuticals News

Aktie
WKN:  A3E2E8 ISIN:  US64132R4048 US-Symbol:  NRBO
3,92 $
+0,00 $
0,00%
14.06.24 15:30:00
Handeln Depot/Watchlist
Aktienanzahl *
4,85 Mio.
Marktkapitalisierung *
17,27 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 20.03.2024

NeuroBo Pharmaceuticals News

20.07.21 - PR Newswire
Thinking about buying stock in Neurobo Pharmaceuticals, Xenetic Biosciences, Amneal Pharmaceuticals, PLx Pharma, or Orbital Energy Group?
Thinking about buying stock in Neurobo Pharmaceuticals, Xenetic Biosciences, Amneal Pharmaceuticals, PLx Pharma, or Orbital Energy Group? PR Newswire
12.07.21 - PR Newswire
NeuroBo Pharmaceuticals' Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors
NeuroBo Pharmaceuticals' Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors Experienced Leaders Bring More Than 30 Years of Industry ...
17.05.21 - PR Newswire
NeuroBo Pharmaceuticals Reports First Quarter 2021 Financial Results
NeuroBo Pharmaceuticals Reports First Quarter 2021 Financial Results PR Newswire
15.04.21 - PR Newswire
NeuroBo Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Strategic Update
NeuroBo Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Strategic Update Acquisition of ANA Therapeutics provides late-​stage COVID-19 ...
24.03.21 - PR Newswire
NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene
NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene Gemcabene to be Studied as a Stand-​alone Treatment for COVID-19 and ...
05.03.21 - PR Newswire
NeuroBo Pharmaceuticals to Participate in H.C. Wainwright Global Life Sciences Conference
NeuroBo Pharmaceuticals to Participate in H.C. Wainwright Global Life Sciences Conference PR Newswire
21.01.21 - PR Newswire
NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement
NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement PR Newswire
19.01.21 - PR Newswire
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement PR Newswire
06.01.21 - PR Newswire
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-​Stage Oral Antiviral Development Program Transformative Acquisition Deepens Pipeline with In-​Process Phase 2/3 ...
13.11.20 - PR Newswire
NeuroBo Pharmaceuticals Reports Third Quarter 2020 Financial Results
NeuroBo Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire

Newssuche

Videos

13.06.24 -3,86%
Technical Trading: Zukauf-​Chance bei Top-Trade, wenn
Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: prozyklisch ... Mehr »